This event has already occurred.

John M. Vierling, MD

John M. Vierling, MD

Risks of Pegylated Interferon Therapies for HCV Infections in Patients with Cirrhosis


February 28, 2014, 1:00 p.m. to 2:00 p.m.


John M. Vierling, MD

Professor, Medicine and Surgery; Chief of Hepatology; Director, Baylor Liver Health; Director, Advanced Liver Therapies; Baylor College of Medicine, St. Luke's Episcopal Hospital, Houston, TX


Fralin Biomedical Research Institute, M106
2 Riverside Circle, Roanoke, VA 24016

More than three million people in the United States are believed to have chronic hepatitis C virus infection. In this seminar, Dr. Vierling will discuss up-to-date data on the efficacy of non-interferon antiviral therapies for hepatitis C infection.

Additional Details

This is a free event. The host is Michael Friedlander, PhD. For more information, please call 540-526-2059, or send an e-mail.

Map and Parking

This map shows where the Fralin Biomedical Research Institute is located in Roanoke, VA at 2 Riverside Circle.

Parking is available in the parking garage across the street.

Click the "Google" logo for a larger version.

Event Type